HUTCHMED (China) Ltd (HCM)
Industry Drug Manufacturers - Specialty & Generic
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
196.50p
Buy
202.00p
2.00p (+1.00%)
Prices updated at 17 Dec 2025, 12:04 GMT
| Prices minimum 15 mins delay
Prices in GBX
Hutchison China Meditech Ltd is a major drug manufacturing company. The company operates two platforms--an innovation platform and a commercial platform aimed at discovering and developing therapeutics in oncology and autoimmune diseases.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
Valuation
Profit margins data table
Year | Gross margin (%) |
|---|---|
| 2024 | 44.64 |
| 2023 | 54.12 |
| 2022 | 27.04 |
| 2021 | 27.49 |
| 2020 | 17.31 |
| 2019 | 21.84 |
| 2018 | 32.77 |
| 2017 | 27.11 |
| 2016 | 27.65 |
| 2015 | 37.84 |
Valuation data table
Year | Price / Sales |
|---|---|
| 2025 | 3.88 |
| 2024 | 4.21 |
| 2023 | 4.07 |
| 2022 | 6.77 |
| 2021 | 18.49 |
| 2020 | 20.22 |
| 2019 | 15.48 |
| 2018 | 13.23 |
| 2017 | 19.27 |
| 2016 | 8.03 |
| 2015 | 14.39 |
Price/Forward earnings (YTD)
20.88
Returns
Debt profile
Returns data table
Year | Return on assets (%) |
|---|---|
| 2024 | 2.95 |
| 2023 | 8.73 |
| 2022 | -30.04 |
| 2021 | -18.57 |
| 2020 | -21.14 |
| 2019 | -21.26 |
| 2018 | -13.24 |
| 2017 | -5.69 |
| 2016 | 4.09 |
| 2015 | -15.90 |
Debt profile data table
| Year | Financial leverage |
|---|---|
| 2024 | 1.68 |
| 2023 | 1.75 |
| 2022 | 1.69 |
| 2021 | 1.39 |
| 2020 | 1.50 |
| 2019 | 1.61 |
| 2018 | 1.37 |
| 2017 | 1.29 |
| 2016 | 1.86 |
| 2015 | 2.75 |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.
